TTRX
Turn·NASDAQ
--
--(--)
--
--(--)
TTRX Profile
Turn Therapeutics Inc.
Dedicated to improving healthcare systems in low-and middle-income countries
Life Science Tools and Services
01/06/2015
10/08/2025
NASDAQ Stock Exchange
2
12-31
Common stock
250 N. Westlake Blvd.
Westlake Village
CA 91362
--
Turn Therapeutics Inc., originally formed on January 6, 2015, is a Delaware limited liability company. The company is a pharmaceutical and medical device development company with core technologies based on proprietary platforms designed to enhance drug performance. Its patented blending process — commercially known as PermaFusion — enables the stable suspension of polar water-soluble active pharmaceutical ingredients (" APIs ") in oily carriers without the use of emulsifiers. Its main development projects focus on skin diseases, including moderate to severe eczema and onychomycosis.
